Ingestible Sensor System for HIV/AIDS (Sensor-SBDOH Trial)
Palo Alto (17 mi)Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: University of California, Los Angeles
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?This study integrates technology-based adherence measures with alerts for social and behavioral determinants of health (SBDOH) to improve HIV treatment outcomes. It involves 110 adult patients from a Los Angeles County HIV clinic, focusing on those at risk for poor adherence. Participants will be randomized into intervention or usual care groups, with endpoints including intervention acceptability, SBDOH interventions, adherence to ART, viral load, and high-risk sexual activity. The study aims to assess the effectiveness of the integrated intervention in improving adherence, virologic outcomes, and reducing high-risk behavior among PLWH.
Eligibility Criteria
This trial is for adults with HIV from a Los Angeles County clinic, particularly those who struggle to stick to their treatment. Participants must be willing to use a pill sensor system that tracks medication intake and alerts for social and behavioral health issues.Inclusion Criteria
I am HIV positive and currently receiving treatment for it.
I am older than 17 years.
I can take ARV medication as prescribed.
I am on antiretroviral therapy with specific medications.
Exclusion Criteria
I am mentally and physically able to follow the study's procedures without confusion or risky behavior.
Treatment Details
The study tests an integrated intervention using a pill ingestible sensor system (ISS) combined with support for social and behavioral determinants of health (SBDOH). It compares usual care against this new approach in terms of adherence, viral load control, and risky sexual behavior reduction.
2Treatment groups
Experimental Treatment
Active Control
Group I: ISS-SBDOH armExperimental Treatment1 Intervention
Ingestion Sensor System (ISS) - Social and Behavioral Determinants of Health (SBDOH) arm
Group II: Usual Care (UC) armActive Control1 Intervention
Usual Care (UC) arm
UC is chosen as the control condition because it meets ethical and moral requirements to attempt treatment.
Find a clinic near you
Research locations nearbySelect from list below to view details:
LundquistLos Angeles, CA
Loading ...
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)Collaborator
EtectRX, Inc.Industry Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCollaborator